Pediatric Endocrinol
Once a treatment plan is created, youll receive subcutaneous injections of CJC-1295 and Ipamorelin, typically administered in the evening to align with your natural circadian rhythm
Trial evidence: Tesamorelin 2mg SC daily sustained GH/IGF-1 elevation, 15-18% visceral fat reduction over 6 months (Falutz, NEJM 2007, PMID 17699044) Ipamorelin 200-300 mcg peak GH 5-10x baseline within 30 minutes, no cortisol/prolactin bump (Raun, EJE 1998, PMID 9539826) GHRH + GHRP synergy 2-3x greater amplitude than either alone (Bowers, JCEM 1991, PMID 2004615) Community protocols extend this evidence base with cycling patterns that weren't studied in the original trials the 5-on/2-off rhythm and 8-week cycles are empirical community consensus, not clinically validated
Growth-hormone secretagogues including GHRH and its analogs such as CJC-1295, and growth-hormone-releasing peptides (GHRPs) such as Ipamorelin are prohibited at all times under section S2 of the WADA Prohibited List (Peptide Hormones, Growth Factors, Related Substances and Mimetics)
The latter could be the result of Tesamorelins ability to reduce visceral fat and preserve lean muscle
We will put together a treatment plan that meets your individual needs and ensures the absolute best results
